Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.515)

41

Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents : an approach for drug use

enthalten in: European journal of hospital pharmacy : science and practice | 2024

von Visscher, R. | Yalçın, N. | Bayraktar, I. | +1

42

A pilot study on Paxlovid therapy for hemodialysis patients with severe acute respiratory syndrome coronavirus 2 infections

enthalten in: Frontiers of medicine | 2024

von Hao, X. | Bao, Z. | Dai, R. | +13

43

Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More

enthalten in: JAMA | 2024

von Rubin, R.

44

Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron : An updated meta-analysis

enthalten in: Journal of medical virology | 2024

von Ombelet, S. | Castanares-Zapatero, D. | Desimpel, F. | +3

45

Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19

enthalten in: Journal of Korean medical science | 2024

von Jang, Y. | Oh, Y. | Kim, J.

46

Nirmatrelvir Resistance-de Novo E166V/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure-a Case Report

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Zuckerman, N. | Bucris, E. | Keidar-Friedman, D. | +2

47

Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Gentry, C. | Nguyen, P. | Thind, S. | +2

48

Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19

enthalten in: Journal of medical virology | 2024

von Chang, L. | Chen, I. | Hung, K.

49

Public Health Impact of Paxlovid as Treatment for COVID-19, United States

enthalten in: Emerging infectious diseases | 2024

von Bai, Y. | Du, Z. | Wang, L. | +7

UpdateOf: medRxiv. 2023 Sep 07;:. - PMID 37732213

50

Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China : a multicentre, retrospective cohort study

enthalten in: Annals of medicine | 2024

von Han, X. | Li, C. | Yuan, X. | +22